One of the more frustrating aspects of integrative medicine is the gap between how it's often discussed — either breathlessly by advocates or dismissively by critics — and what the actual research shows. I try to stay in the more uncomfortable middle ground: taking the evidence seriously where it exists, acknowledging uncertainty where it doesn't, and being clear about the difference.

The studies listed below are selected for quality (randomised controlled trials, systematic reviews, and meta-analyses where available) and clinical relevance. This isn't an exhaustive literature review — it's a starting point for people who want to understand the evidence behind the approaches I use.

Gut Microbiome & Probiotics

Strong Evidence

The gut microbiome has become one of the most rapidly expanding areas of biomedical research. While much of the popular coverage has outpaced the evidence, there are now solid findings that translate meaningfully into clinical practice.

Probiotic interventions have the strongest evidence base in specific clinical contexts: antibiotic-associated diarrhoea, Clostridioides difficile infection prevention, IBS (particularly for bloating and altered bowel habit), and infantile colic. The evidence for broader claims — mental health, immunity, skin — is growing but requires more large-scale trials before confident clinical recommendations can be made.

  • Efficacy of probiotics in IBS: a meta-analysis of randomised controlled trialsFord et al., American Journal of Gastroenterology, 2018→ Probiotics significantly reduced global IBS symptoms and abdominal pain compared to placebo (RR 0.79)
  • Gut microbiota in health and disease: current understandingShreiner et al., Current Opinion in Gastroenterology, 2015→ Comprehensive review establishing causal links between dysbiosis and IBD, metabolic disease, and CNS disorders
  • Diet rapidly and reproducibly alters the human gut microbiomeDavid et al., Nature, 2014→ Dietary composition shifts microbiome composition within 24–48 hours; fibre diversity drives beneficial bacterial diversity

Herbal Medicine: Adaptogens & Stress

Moderate Evidence

Adaptogenic herbs — plants that appear to help the body resist and recover from physical and psychological stress — have a long history in traditional medicine systems and an increasingly solid evidence base in modern research. The evidence is strongest for ashwagandha, Rhodiola rosea, and Panax ginseng.

The mechanism of action for most adaptogens involves modulation of the HPA axis and sympathoadrenal system — the same pathways activated by chronic stress. This mechanistic plausibility strengthens the clinical findings, though most human trials remain relatively small.

  • Ashwagandha root extract reduces stress and anxiety: a double-blind RCTChandrasekhar et al., Indian Journal of Psychological Medicine, 2012→ 300mg twice daily significantly reduced serum cortisol and self-reported stress scores vs placebo over 60 days
  • Rhodiola rosea for mental fatigue: a randomised, double-blind, placebo-controlled studySpasov et al., Phytomedicine, 2000→ Significant improvement in mental fatigue, physical performance, and neuro-motor speed in medical students during exam period
  • A systematic review of adaptogenic plants used in traditional medicinePanossian & Wikman, Pharmaceuticals, 2010→ Review of 68 studies supporting the concept and clinical evidence for plant adaptogens

Nutritional Interventions: Omega-3 & Inflammation

Strong Evidence

The anti-inflammatory properties of long-chain omega-3 fatty acids (EPA and DHA, found in oily fish and algae-derived supplements) represent one of the most robustly supported areas of nutritional medicine. Their effects on cardiovascular risk, inflammatory markers, and mood have been studied extensively over several decades.

The clinical applications I use most often relate to inflammatory conditions, mood disorders, and cardiovascular risk reduction. Dosing matters significantly: anti-inflammatory effects generally require higher doses (2–4g EPA+DHA/day combined) than most "fish oil" supplements contain.

  • Omega-3 supplementation and depression: a meta-analysisLiao et al., Translational Psychiatry, 2019→ EPA-dominant supplements showed significant antidepressant effects; DHA-dominant preparations showed weaker effects
  • Marine omega-3 supplementation and cardiovascular disease: meta-analysis of 13 RCTsHu et al., Journal of the American Heart Association, 2019→ Significant reductions in cardiac mortality, MI, and CAD events at doses ≥1g/day
  • Dietary n-3 fatty acids and systemic inflammationCalder, Proceedings of the Nutrition Society, 2012→ Comprehensive mechanistic and clinical review of anti-inflammatory effects of EPA and DHA

Gut-Brain Axis & Mental Health

Emerging Evidence

The bidirectional communication between the gut and the brain — via the vagus nerve, immune signalling, and the production of neurotransmitter precursors by gut bacteria — is one of the most exciting areas of current research. It is also one of the most over-stated in popular health media.

What is well-established is that gut health and mental health are significantly correlated. What remains to be clarified is the precise directionality and mechanism in various conditions, and which microbiome interventions most effectively translate into mental health outcomes in different populations. The "psychobiotics" concept is promising but still early-stage.

  • The gut microbiota and the brain: a promising partnershipCryan & Dinan, Nature Reviews Neuroscience, 2012→ Foundational review establishing the mechanistic basis of gut-brain communication
  • Psychobiotics: a novel class of psychotropic — a systematic reviewDinan et al., Biological Psychiatry, 2013→ Introduced the concept; evidence for specific strains influencing anxiety and mood in clinical populations
  • Probiotic supplementation and mental health in healthy adults: systematic reviewPirbaglou et al., Nutrition Research, 2016→ Positive effects on depression and anxiety scores in healthy volunteers; cautious interpretation due to small sample sizes

Vitamin D & Immune Function

Strong Evidence

Vitamin D deficiency is endemic in northern European populations, with estimates suggesting over 40% of UK adults are deficient, rising to over 70% in some at-risk groups. Its role extends significantly beyond bone health — it functions more accurately as a hormone, with receptors in virtually every cell type.

The evidence for vitamin D in immune function, mood, and autoimmune conditions has strengthened considerably over the past decade. Deficiency is now consistently associated with increased risk of respiratory infection, multiple sclerosis progression, and depression — though supplementation trials show more heterogeneous results, likely due to baseline status confounding.

  • Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysisMartineau et al., BMJ, 2017→ Overall protective effect; strongest in those with baseline deficiency (25-OHD <25 nmol/L)
  • Association between vitamin D status and depression in adultsAnglin et al., British Journal of Psychiatry, 2013→ Consistent association between low vitamin D and depression across multiple study designs

This page is for educational purposes and does not constitute medical advice. Research findings in nutritional and integrative medicine continue to evolve rapidly. The studies cited here represent selected high-quality evidence as of mid-2026 — not an exhaustive review. Always work with a qualified practitioner before starting any supplementation protocol.